Healthcare Ai Acquisition CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Healthcare AI Acquisition Corp. issued a supplement clarifying the date, time, and redemption procedures for its upcoming Extraordinary General Meeting on October 10, 2025.
Healthcare AI Acquisition Corp. has postponed its Extraordinary General Meeting to October 10, 2025, and proposes to extend its business combination deadline from March 14, 2026, to October 14, 2026.
Healthcare AI Acquisition Corp. (HAIA) is seeking shareholder approval to extend its business combination deadline to March 14, 2026, to complete its merger with China-based Leading Group Limited.
Healthcare AI Acquisition Corp. announces the adjournment of its Extraordinary General Meeting of Shareholders to April 30, 2025.
DEF: Healthcare AI Acquisition Corp. Seeks Extension to Complete Business Combination with Leading Group
Healthcare AI Acquisition Corp. is seeking shareholder approval to extend the deadline for completing its business combination with Leading Group from May 14, 2025, to October 14, 2025, to allow additional time to finalize the transaction.
Healthcare AI Acquisition Corp. is facing a Nasdaq delisting deadline of December 9, 2024, and is seeking monthly extensions to complete a business combination.
Healthcare AI Acquisition Corp. releases a supplement to its proxy statement, updating the redemption price per share to approximately $11.57 based on trust account balance as of November 1, 2024.
DEF 14A: Healthcare AI Acquisition Corp. Seeks Extension to Complete Business Combination with Leading Group
Healthcare AI Acquisition Corp. is seeking shareholder approval to extend the deadline for completing a business combination from December 14, 2024, to May 14, 2025, to finalize its merger with Leading Group.